Cargando…

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage‐specific chimerism analysis

Relapse is a major cause of treatment failure after hematopoietic stem cell transplantation (HSCT) for acute leukemia. Here, we report a monocentric retrospective study of all HSCTs for B cell acute lymphoblastic leukemia (ALL) performed during the years 2005–2021 (n = 138, including 51 children), a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindahl, Hannes, Valentini, Davide, Vonlanthen, Sofie, Sundin, Mikael, Björklund, Andreas T., Mielke, Stephan, Hauzenberger, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Cell Therapy/Stem Cell Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713209/ https://www.ncbi.nlm.nih.gov/pubmed/36467849 http://dx.doi.org/10.1002/jha2.568

Ejemplares similares

Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
por: Lindahl, Hannes, et al.
Publicado: (2022)

Global longitudinal strain is superior to ejection fraction for long‐term follow‐up after allogeneic hematopoietic stem cell transplantation
por: Watanabe, Marika, et al.
Publicado: (2022)

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia
por: Kim, Dennis D. H., et al.
Publicado: (2022)

Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children
por: Rudebeck, Carl J., et al.
Publicado: (2022)

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia
por: Ichikawa, Hiroya, et al.
Publicado: (2023)

Assessment of monocytic‐myeloid‐derived suppressive cells (M‐MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients
por: Peterlin, Pierre, et al.
Publicado: (2023)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

siRNA against CD40 delivered via a fungal recognition receptor ameliorates murine acute graft‐versus‐host disease
por: Heissig, Beate, et al.
Publicado: (2022)

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis
por: Lim, Yeong Jer, et al.
Publicado: (2022)

A systematic literature review of the clinical signs and symptoms of veno‐occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation in adults and children
por: Angus, James, et al.
Publicado: (2022)

A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies
por: Duarte, Gustavo de Carvalho, et al.
Publicado: (2023)

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2022)

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward
por: Leonard, Jessica T., et al.
Publicado: (2018)

Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
por: Kanaan, Sami B., et al.
Publicado: (2023)

Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
por: Xiang, Jingyu, et al.
Publicado: (2022)

Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning
por: Schwaiger, Elisabeth, et al.
Publicado: (2012)

Stem cell transplantation
por: Schaap, Nicolaas
Publicado: (2019)

Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations
por: Togarrati, Padma Priya, et al.
Publicado: (2019)

Recent progress in satellite cell/myoblast engraftment – relevance for therapy
por: Briggs, Deborah, et al.
Publicado: (2013)

Role of microvascular endothelial cells on proliferation, migration and adhesion of hematopoietic stem cells
por: Lin, Fanli, et al.
Publicado: (2020)

PET‐based radiomics signature can predict durable responses to CAR T‐cell therapy in patients with large B‐cell lymphoma
por: Ligero, Marta, et al.
Publicado: (2023)

Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias
por: Spadea, Manuela, et al.
Publicado: (2021)

Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages
por: Spensberger, Dominik, et al.
Publicado: (2012)

Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease
por: García-Sancho, Javier, et al.
Publicado: (2017)

Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus
por: Wang, Xin, et al.
Publicado: (2021)

The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities
por: Hassanein, Mona, et al.
Publicado: (2021)

De Novo Circulating Antidonor's Cell Antibodies During Induced Acute Rejection of Allogeneic Myofibers in Myogenic Cell Transplantation: A Study in Nonhuman Primates
por: Skuk, Daniel, et al.
Publicado: (2017)

Abstract 6 Projected Impact of Omidubicel on Racial and Ethnic Disparities in Allogeneic Hematopoietic Cell Transplant Access and Outcomes for Patients with Hematologic Malignancies in the U.S.
por: Gergis, Usama, et al.
Publicado: (2022)

T cell receptor excision circles are potential predictors of survival in adult allogeneic hematopoietic stem cell transplantation recipients with acute myeloid leukemia
por: Söderström, Anna, et al.
Publicado: (2022)

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2023)

Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients
por: Gama, Bianca E., et al.
Publicado: (2017)

The genesis of human hematopoietic stem cells
por: Calvanese, Vincenzo, et al.
Publicado: (2023)

Isolation of a Highly Purified HSC-enriched CD34(+)CD90(+)CD45RA(−) Cell Subset for Allogeneic Transplantation in the Nonhuman Primate Large-animal Model
por: Radtke, Stefan, et al.
Publicado: (2020)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
por: Malagola, Michele, et al.
Publicado: (2023)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Hematopoietic stem cell aging and leukemia transformation
por: Colom Díaz, Patricia A., et al.
Publicado: (2023)

Brg1 modulates enhancer activation in mesoderm lineage commitment
por: Alexander, Jeffrey M., et al.
Publicado: (2015)

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
por: Martin, Paul J., et al.
Publicado: (2022)

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
por: Miyata, Masahiro, et al.
Publicado: (2023)

Infectious disease in hematopoietic stem cell transplantation
por: Sahu, Kamal Kant
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g8vtj4t6erl9hu2aubhjl02t8h